Q4 2024 Rossari Biotech Ltd Earnings Call Transcript
Key Points
- Rossari Biotech Ltd (BOM:543213) reported a healthy year-on-year growth in both revenues and profits, driven by the expansion of the HPPC business.
- The company achieved significant success in exports, which grew faster than domestic markets during the year.
- Rossari Biotech Ltd (BOM:543213) expanded its customer base for key HPPC products, leading to a robust 18% growth in the division.
- The Institutional Cleaning segment achieved exceptional results, serving major sectors such as airports, railways, hotels, and healthcare.
- The company maintains a strong balance sheet and disciplined financial management, supporting its long-term growth strategy.
- Challenges persisted in the Textile Specialties (TSC) and Animal Health and Nutrition (AHN) divisions due to external industry headwinds.
- The textile division witnessed a slowdown this quarter, primarily due to subdued demand in the textile industry and the softening of prices.
- Gross margins were impacted by a change in product mix and moderation in selling prices.
- High inventories and receivables have increased during the year, stressing the working capital cycle.
- The company faces competitive intensity in the industry, affecting its ability to maintain stable margins amidst raw material price volatility.
Ladies and gentlemen, good day and welcome to the Rossari Biotech Limited earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Anoop Poojari, from CDR India. Thank you, and over to you, Mr. Poojari.
Thank you. Good evening, everyone, and thank you for joining us on Rossari Biotech's Q4 and FY24 earnings conference call. We have with us Mr. Edward Menezes, from Promoter and Executive Chairman; Mr. Sunil Chari, Promoter and Managing Director; and Mr. Ketan Sablok, Group Chief Financial Officer of the company.
We will begin the call with opening remarks from the management, following which we'll have the forum open for a question-and-answer session. Before we start, I would like to point out that some statements made in today's call may be forward-looking in nature and a disclaimer to this effect has been included in the earnings presentation shared with you earlier.
I would now like to invite Mr. Edward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
